Tempo Therapeutics Secures Series A Financing to Advance Cutting-Edge Tissue Scaffold Products into Clinical Trials ...Middle East

SAN DIEGO, March 19, 2024 /PRNewswire/ -- Tempo Therapeutics, Inc ("Tempo") a leading innovator in tissue engineering and regenerative medicine, today announced the successful completion of its $12 million Series A equity financing round, led by Galaxy-Sirius Partners and Johnson &...

Hence then, the article about tempo therapeutics secures series a financing to advance cutting edge tissue scaffold products into clinical trials was published today ( Wednesday 20/03/2024 - 12:36 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Tempo Therapeutics Secures Series A Financing to Advance Cutting-Edge Tissue Scaffold Products into Clinical Trials )

Also on site :

• ASPEED Technology and Lattice Semiconductor Announce Strategic Partnership to Advance Next-Generation Control for Datacenter Management
• Three Oil and Two Gas Carriers Clear Hormuz
• TestMu AI amplía KaneAI con funciones mejoradas de creación de pruebas y grabación avanzada